培力奇 PRGO
$15.85 +$0.14 (+0.89%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $15.85 0.00%
开盘$15.50
昨收$15.71
当日区间$15.25 – $15.97
成交量2.31M
市值$2.20B
市盈率（TTM）–
股息率7.32%
PRGO 相关新闻
匹配 Perrigo 或代码 PRGO 的头条新闻，按最新排序。
- Perrigo | SCHEDULE 13G/A: Others
- Perrigo | 4: Statement of changes in beneficial ownership of securities-Director Alford Bradley A
- Perrigo | 4: Statement of changes in beneficial ownership of securities-Director Parker Geoffrey M.
- Perrigo | 4: Statement of changes in beneficial ownership of securities-Officer Ball David
- Earnings Flash (PRGO) Perrigo Company Plc Posts Q2 Adjusted EPS $0.50 per Share, Vs. FactSet Est of $0.34
- GUIDANCE: (PRGO) Perrigo Expects 2026 Adjusted EPS Range $2.00 - $2.30, Vs. FactSet Est of $2.12
- Earnings Flash (PRGO) Perrigo Company Plc Reports Q2 Revenue $1.02B, Vs. FactSet Est of $1.01B
- Perrigo Q2 Adj. EPS $0.50 Beats $0.34 Estimate, Sales $1.023B Beat $1.013B Estimate 正面
- Analysts' Top Healthcare Picks: OrthoPediatrics (KIDS), Perrigo Company (PRGO)
- CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $17
- Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO) and Zymeworks (ZYME)
- 4: Perrigo | 4: Statement of changes in beneficial ownership of securities-Director Parker Geoffrey M.
- Perrigo | 4: Statement of changes in beneficial ownership of securities-Director Parker Geoffrey M.
- Perrigo | 4: Statement of changes in beneficial ownership of securities-Director Parker Geoffrey M.
- Perrigo Price Target Cut to $17.00/Share From $20.00 by Canaccord Genuity 负面
暂无评论——快来第一个聊聊 PRGO。
登录后参与讨论。